Home/ Stocks/ CLNN

Clene Inc. Common Stock

CLNN XNAS

$4.63 +0.05 (+1.06%) ▲ 15-min delayed

Open

$4.88

High

$5.05

Low

$4.50

Volume

75.4K

Market Cap

$54.59M

About Clene Inc. Common Stock

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 76 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$15.0K	$-8,777,000	$-0.85
Q2 2025	$27.0K	$-7,419,000	$-0.78
Q1 2025	$81.0K	$-751,000	$-0.09
FY 2024	$342.0K	$-39,400,000	$-5.67

Ticker Daily Articles on CLNN

Penny Stock Risk Management: The Rules That Keep You Alive

Marcus Rivera · 3h ago · News

Get CLNN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Clene Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.